Developer docs
API playgroundTry for free, no card

Search company profiles

MFC Global

Full company profile

uuid002sykr

Namestring
MFC Global
Legal namestring
MFC Global Ltd.
Websiteurl
mfc-global.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

MFC Global Ltd. is a privately held Israeli medical device company founded in 2013 by Pnina Berkovitz (CEO), Dr. Arie Berkovitz (CMO), and Dr. Pavel Itsykson (CTO), headquartered in Rishon LeZion with a secondary office in Givat Shmuel. The company develops and commercializes the SpermVD, an injection-molded polycarbonate medical device for vitrification-based cryopreservation of small numbers of spermatozoa — including single sperm cells — and the complementary SpermVD DISH Petri dish accessory. Both products are CE marked; the SpermVD is additionally FDA registered and ARTG registered. The underlying technology addresses severe male infertility cases (azoospermia, crypto-azoospermia, oligozoospermia) where traditional cryopreservation methods (mini-straws, ICSI pipette, cryoloop) have proven inadequate, with published clinical evidence of 96% post-warm retrieval and 55% clinical pregnancy rates.

MFC Global monetizes through two product SKUs sold in boxes of 25 units (SpermVD at $1,750 USD per box; SpermVD DISH at $390 USD per box) and through cryopreservation services delivered via its associated laboratory at Assuta Medical Center. Distribution is dual-track: direct e-commerce via the company website with PayPal processing for uncovered geographies, and a network of eleven authorized regional distributors spanning Europe (Denmark, Germany, Greece, Italy, Russia, Spain, Turkey), Asia (India, Vietnam), and the Americas (Brazil, Canada). Primary customers are IVF clinics, fertility laboratories, and embryologists; secondary end beneficiaries are male fertility patients facing cancer treatment, advancing age, or severe male-factor infertility.

The company is bootstrapped, with no disclosed institutional funding, M&A activity, or leadership turnover since founding. Growth is driven by scientific publication, peer-reviewed clinical validation, multi-jurisdiction regulatory clearance, and incremental geographic expansion through distributor partnerships rather than capital-intensive sales scaling. Key opinion leader credibility is anchored by co-founder Dr. Arie Berkovitz, inventor of the IMSI method, and by Dr. Pavel Itsykson's ongoing role as IVF laboratory director at Assuta Medical Center.

Short descriptiontext

MFC Global is an Israeli privately held medical device company founded in 2013 that develops and sells the SpermVD, a CE-marked, FDA-registered vitrification device for cryopreserving small numbers of spermatozoa, serving IVF clinics, fertility laboratories, and embryologists worldwide through distributors and direct e-commerce.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRishon Leziyyon, Israel
HQ citystring
Rishon Leziyyon
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sperm cryopreservation devices, male fertility preservation, assisted reproductive technology, sperm vitrification equipment, IVF laboratory consumables
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
Product category
Fertility Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1SpermVD Device Sales
TypeHardware Sales
Description

Sale of SpermVD cryopreservation devices - sterile, disposable single-use devices sold in boxes of 25 units. Revenue generated from direct online sales and through distributor network globally.

mfc-global.com
2SpermVD DISH Accessory Sales
TypeHardware Sales
Description

Sale of SpermVD DISH accessories - complementary products designed to enhance and optimize the freezing and warming process. Sold in boxes of 25 units.

mfc-global.com
3Cryopreservation Services
TypeProfessional Services
Description

The company operates an associated laboratory that provides IVF and cryopreservation services to customers in Israel and abroad.

mfc-global.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details2 tiers
1SpermVD - Box of 25 units
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Price: $1,750 USD (~1,490 Euro) per box of 25 units. Shipping costs included. Single SpermVD dimensions: 26 x 8 x 7 mm, weight 0.2 grams. SKU: SPVD-1.

mfc-global.com
2SpermVD DISH - Box of 25 units
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Price: $390 USD (~330 Euro) per box of 25 units. SKU: SPVD-2. Note: Import and custom taxes apply to customer and will be added to the mentioned prices.

mfc-global.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1SpermVD
Description

Innovative medical device for cryopreservation of small numbers of spermatozoa, enabling vitrification from a single cell to thousands. CE marked, FDA and ARTG registered.

mfc-global.com
+1 more record
Core offering1 text field

MFC Global designs, manufactures and sells the SpermVD, a proprietary CE-marked, FDA-registered medical device for vitrification-based cryopreservation of small numbers of spermatozoa (single cell to thousands). The company also offers the SpermVD DISH accessory Petri dish optimized for SpermVD workflows, and operates an associated laboratory providing sperm cryopreservation services to IVF clinics in Israel and abroad.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 96% post-warm retrieval rate of frozen spermatozoa
+5 more records
Product overview1 text field

MFC Global offers a focused product portfolio centered on the SpermVD, an innovative medical device for vitrification-based cryopreservation of small numbers of spermatozoa. The core SpermVD product works in conjunction with the SpermVD DISH accessory, which provides a purpose-designed dish to enhance handling and processing. The company also provides related cryopreservation services through its associated laboratory. All products are designed for use in IVF clinics and laboratories treating male infertility cases including azoospermia, cryptoazoospermia, and oligoazoospermia.

Product and service1 record
1SpermVD
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Denmark. Markets and sells MFC Global products including SpermVD and SpermVD DISH to fertility clinics in the Nordic region.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Germany. Markets and sells MFC Global products to fertility clinics and laboratories.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Greece. Markets and sells MFC Global products to fertility clinics in Greece.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Italy. Markets and sells MFC Global products to fertility clinics and laboratories in Italy.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Russian Federation. Markets and sells MFC Global products to fertility clinics in Russia.

6CIMAB IBERICA S.L.
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Spain. Markets and sells MFC Global products to fertility clinics and laboratories in Spain.

mfc-global.com
7Bil-Tek
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Turkey. Markets and sells MFC Global products to fertility clinics in Turkey.

mfc-global.com
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Brazil. Markets and sells MFC Global products to fertility clinics in Brazil.

9Intermedics
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for India. Markets and sells MFC Global products to fertility clinics and laboratories in India.

mfc-global.com
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Vietnam. Markets and sells MFC Global products to fertility clinics and medical facilities in Vietnam.

11Fertitech Canada
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Canada. Markets and sells MFC Global products to fertility clinics and laboratories in Canada.

mfc-global.com
12Assuta Medical Center
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The company operates its associated laboratory at Assuta Medical Center in Rishon Le-zion, Israel. Dr. Pavel Itsykson serves as IVF laboratory Director at Assuta. Products are tested and used routinely in this clinical setting.

mfc-global.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Vitrolife is a global leader in IVF media, consumables, and devices serving embryologists and fertility clinics. With its established product portfolio, global sales coverage, and clinical evidence base, it competes with MFC Global across the broader ART consumables space where the SpermVD is positioned.

2Midatlantic Diagnostics / Cryobio (MTG Medical)
TypeEmerging player
Description

MTG Medical / Cryobio supplies cryopreservation devices and tools for sperm, oocytes, and embryos across fertility clinics. It is comparable to MFC Global as a focused ART cryopreservation consumables specialist.

TypeDirect peer
Description

Kitazato is a Japanese ART consumables company best known for its Cryotop vitrification device for oocytes and embryos, and also supplies cryopreservation tools for sperm. It is the most direct competitor to MFC Global in the vitrification consumables category, addressing the same IVF clinic and embryologist customer base.

TypeBroad incumbent
Description

FUJIFILM Irvine Scientific is a broad ART media and consumables supplier offering culture media, vitrification solutions, and devices across the IVF workflow. As a large established player with global distribution, it competes with MFC Global on adjacent cryopreservation products and has the scale to bundle or replicate sperm vitrification solutions.

TypeEmerging player
Description

Bio-Techne supplies ART media and consumables used in IVF workflows including cryopreservation. Its portfolio overlap with MFC Global centers on consumables used by embryologists to handle and preserve gametes.

TypeBroad incumbent
Description

Hamilton Thorne supplies laser systems, micromanipulators, and related ART devices used in ICSI and cryopreservation workflows. As a supplier to embryologists globally, it competes in adjacent parts of the same clinical process where SpermVD is employed.

TypeDirect peer
Description

Genea Biomedx develops and sells ART devices and consumables, including vitrification and culture tools, targeting the same embryologist and IVF lab customer base. Its range of cryopreservation and micromanipulation products directly overlaps with the workflow where the SpermVD is used.

TypeBroad incumbent
Description

CooperSurgical's fertility portfolio includes Wallace, ORIGIO, and Research Instruments lines covering ART devices, micromanipulators, and consumables. It is a broad incumbent with overlapping sperm handling, ICSI, and vitrification products sold to the same fertility clinic audience.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MFC Global

Fertility Medical Devicesmfc-global.com

MFC Global is an Israeli privately held medical device company founded in 2013 that develops and sells the SpermVD, a CE-marked, FDA-registered vitrification device for cryopreserving small numbers of spermatozoa, serving IVF clinics, fertility laboratories, and embryologists worldwide through distributors and direct e-commerce.

What MFC Global does

MFC Global Ltd. is a privately held Israeli medical device company founded in 2013 by Pnina Berkovitz (CEO), Dr. Arie Berkovitz (CMO), and Dr. Pavel Itsykson (CTO), headquartered in Rishon LeZion with a secondary office in Givat Shmuel. The company develops and commercializes the SpermVD, an injection-molded polycarbonate medical device for vitrification-based cryopreservation of small numbers of spermatozoa — including single sperm cells — and the complementary SpermVD DISH Petri dish accessory. Both products are CE marked; the SpermVD is additionally FDA registered and ARTG registered. The underlying technology addresses severe male infertility cases (azoospermia, crypto-azoospermia, oligozoospermia) where traditional cryopreservation methods (mini-straws, ICSI pipette, cryoloop) have proven inadequate, with published clinical evidence of 96% post-warm retrieval and 55% clinical pregnancy rates.

MFC Global monetizes through two product SKUs sold in boxes of 25 units (SpermVD at $1,750 USD per box; SpermVD DISH at $390 USD per box) and through cryopreservation services delivered via its associated laboratory at Assuta Medical Center. Distribution is dual-track: direct e-commerce via the company website with PayPal processing for uncovered geographies, and a network of eleven authorized regional distributors spanning Europe (Denmark, Germany, Greece, Italy, Russia, Spain, Turkey), Asia (India, Vietnam), and the Americas (Brazil, Canada). Primary customers are IVF clinics, fertility laboratories, and embryologists; secondary end beneficiaries are male fertility patients facing cancer treatment, advancing age, or severe male-factor infertility.

The company is bootstrapped, with no disclosed institutional funding, M&A activity, or leadership turnover since founding. Growth is driven by scientific publication, peer-reviewed clinical validation, multi-jurisdiction regulatory clearance, and incremental geographic expansion through distributor partnerships rather than capital-intensive sales scaling. Key opinion leader credibility is anchored by co-founder Dr. Arie Berkovitz, inventor of the IMSI method, and by Dr. Pavel Itsykson's ongoing role as IVF laboratory director at Assuta Medical Center.

MFC Global firmographics

Firmographics
Name
MFC Global
Legal name
MFC Global Ltd.
Website
https://mfc-global.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
MFC Global is an Israeli privately held medical device company founded in 2013 that develops and sells the SpermVD, a CE-marked, FDA-registered vitrification device for cryopreserving small numbers of spermatozoa, serving IVF clinics, fertility laboratories, and embryologists worldwide through distributors and direct e-commerce.
Ownership category
akta.pro rank

Where MFC Global is headquartered

Location

Headquarters

HQ city
Rishon Leziyyon
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

MFC Global business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. SpermVD Device Sales: Sale of SpermVD cryopreservation devices - sterile, disposable single-use devices sold in boxes of 25 units. Revenue generated from direct online sales and through distributor network globally.
  2. SpermVD DISH Accessory Sales: Sale of SpermVD DISH accessories - complementary products designed to enhance and optimize the freezing and warming process. Sold in boxes of 25 units.
  3. Cryopreservation Services: The company operates an associated laboratory that provides IVF and cryopreservation services to customers in Israel and abroad.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSpermVD - Box of 25 units
Unit PricingPay-as-you-goSpermVD DISH - Box of 25 units

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

MFC Global product offering

Product offering

Core offering

MFC Global designs, manufactures and sells the SpermVD, a proprietary CE-marked, FDA-registered medical device for vitrification-based cryopreservation of small numbers of spermatozoa (single cell to thousands). The company also offers the SpermVD DISH accessory Petri dish optimized for SpermVD workflows, and operates an associated laboratory providing sperm cryopreservation services to IVF clinics in Israel and abroad.

Product overview

MFC Global offers a focused product portfolio centered on the SpermVD, an innovative medical device for vitrification-based cryopreservation of small numbers of spermatozoa. The core SpermVD product works in conjunction with the SpermVD DISH accessory, which provides a purpose-designed dish to enhance handling and processing. The company also provides related cryopreservation services through its associated laboratory. All products are designed for use in IVF clinics and laboratories treating male infertility cases including azoospermia, cryptoazoospermia, and oligoazoospermia.

Differentiator

Problem solved

Functional benefit

Brands

  • SpermVD: Innovative medical device for cryopreservation of small numbers of spermatozoa, enabling vitrification from a single cell to thousands. CE marked, FDA and ARTG registered.
  • SpermVD DISH

Products and services

  • SpermVD

Quantifiable outcome

  • 96% post-warm retrieval rate of frozen spermatozoa
  • +5 more outcomes

Companies that use MFC Global

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles1 record

MFC Global technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

MFC Global partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered regional and core.

  • Nordic Cell ApSregionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Denmark. Markets and sells MFC Global products including SpermVD and SpermVD DISH to fertility clinics in the Nordic region.
  • Gynemed GmbH & Co. KGregionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Germany. Markets and sells MFC Global products to fertility clinics and laboratories.
  • MEDIPLAN LtdregionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Greece. Markets and sells MFC Global products to fertility clinics in Greece.
  • SOL SPAregionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Italy. Markets and sells MFC Global products to fertility clinics and laboratories in Italy.
  • BMT Ltd.regionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Russian Federation. Markets and sells MFC Global products to fertility clinics in Russia.
  • CIMAB IBERICA S.L.regionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Spain. Markets and sells MFC Global products to fertility clinics and laboratories in Spain.
  • Bil-TekregionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Turkey. Markets and sells MFC Global products to fertility clinics in Turkey.
  • SpectrunregionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Brazil. Markets and sells MFC Global products to fertility clinics in Brazil.
  • IntermedicsregionalChannel Partner/ Reseller/ DistributorAuthorized distributor for India. Markets and sells MFC Global products to fertility clinics and laboratories in India.
  • TOAN ANH CO Ltd.regionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Vietnam. Markets and sells MFC Global products to fertility clinics and medical facilities in Vietnam.
  • Fertitech CanadaregionalChannel Partner/ Reseller/ DistributorAuthorized distributor for Canada. Markets and sells MFC Global products to fertility clinics and laboratories in Canada.
  • Assuta Medical CentercoreStrategic or Co-development PartnerThe company operates its associated laboratory at Assuta Medical Center in Rishon Le-zion, Israel. Dr. Pavel Itsykson serves as IVF laboratory Director at Assuta. Products are tested and used routinely in this clinical setting.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

MFC Global competitors and assessment

Company assessment

Broad incumbents

  • Vitrolife: Vitrolife is a global leader in IVF media, consumables, and devices serving embryologists and fertility clinics. With its established product portfolio, global sales coverage, and clinical evidence base, it competes with MFC Global across the broader ART consumables space where the SpermVD is positioned.
  • FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific is a broad ART media and consumables supplier offering culture media, vitrification solutions, and devices across the IVF workflow. As a large established player with global distribution, it competes with MFC Global on adjacent cryopreservation products and has the scale to bundle or replicate sperm vitrification solutions.
  • Hamilton Thorne: Hamilton Thorne supplies laser systems, micromanipulators, and related ART devices used in ICSI and cryopreservation workflows. As a supplier to embryologists globally, it competes in adjacent parts of the same clinical process where SpermVD is employed.
  • CooperSurgical (Wallace / ORIGIO / Research Instruments): CooperSurgical's fertility portfolio includes Wallace, ORIGIO, and Research Instruments lines covering ART devices, micromanipulators, and consumables. It is a broad incumbent with overlapping sperm handling, ICSI, and vitrification products sold to the same fertility clinic audience.

Emerging players

  • Midatlantic Diagnostics / Cryobio (MTG Medical): MTG Medical / Cryobio supplies cryopreservation devices and tools for sperm, oocytes, and embryos across fertility clinics. It is comparable to MFC Global as a focused ART cryopreservation consumables specialist.
  • Bio-Techne (formerly Trophos / Vitromed): Bio-Techne supplies ART media and consumables used in IVF workflows including cryopreservation. Its portfolio overlap with MFC Global centers on consumables used by embryologists to handle and preserve gametes.

Direct peers

  • Kitazato Corporation: Kitazato is a Japanese ART consumables company best known for its Cryotop vitrification device for oocytes and embryos, and also supplies cryopreservation tools for sperm. It is the most direct competitor to MFC Global in the vitrification consumables category, addressing the same IVF clinic and embryologist customer base.
  • Genea Biomedx: Genea Biomedx develops and sells ART devices and consumables, including vitrification and culture tools, targeting the same embryologist and IVF lab customer base. Its range of cryopreservation and micromanipulation products directly overlaps with the workflow where the SpermVD is used.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

MFC Global social profiles

Digital presence

MFC Global compliance and trust

Trust signal

Compliance3 records

MFC Global financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MFC Global leadership team

Management profile

Number of profiles

Profiles3 records

MFC Global funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MFC Global M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MFC Global

What does MFC Global do?

MFC Global designs, manufactures and sells the SpermVD, a proprietary CE-marked, FDA-registered medical device for vitrification-based cryopreservation of small numbers of spermatozoa (single cell to thousands). The company also offers the SpermVD DISH accessory Petri dish optimized for SpermVD workflows, and operates an associated laboratory providing sperm cryopreservation services to IVF clinics in Israel and abroad.

Is MFC Global a public or private company?

MFC Global is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MFC Global founded?

MFC Global was founded in 2013. It employs 1 to 10 people.

Where is MFC Global based?

MFC Global is headquartered in Rishon Leziyyon, Israel, in the Middle East region.

How does MFC Global make money?

Three revenue lines are on record. SpermVD Device Sales are the primary driver. The others are spermVD DISH Accessory Sales and cryopreservation Services.

Who are MFC Global's main competitors?

Broad incumbents on record are Vitrolife, FUJIFILM Irvine Scientific, Hamilton Thorne and CooperSurgical (Wallace / ORIGIO / Research Instruments). Emerging players are Midatlantic Diagnostics / Cryobio (MTG Medical) and Bio-Techne (formerly Trophos / Vitromed). Direct peers are Kitazato Corporation and Genea Biomedx.

Does MFC Global have an API?

No public API is recorded for MFC Global.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales